Press Releases

The Pathologists Quality Registry expands its quality measures in 2019 to include additional measures for timely and accurate diagnosis of cancer, bloodstream infections, and heart attacks.

The CAP filed an amicus brief in support of the American Clinical Laboratory Association’s appeal to overturn a decision dismissing its lawsuit to correct the Department of Health and Human Services’ execution of reforms to Medicare’s clinical laboratory fee schedule.

With the newest module in the CAP’s Test Ordering Program, “Biomarkers in Colorectal Cancer,” CAP members can handily help other doctors navigate testing and ensure the proper tests are ordered for each patient.

The Centers for Disease Control and Prevention (CDC) awarded the College of American Pathologists (CAP) a five-year, $300,000/year collaborative grant to further address standardization and support for diagnostic cancer and biomarker electronic reporting.

Available now from CAP Press, the Color Atlas of Mycology: An Illustrated Field Guide Based on Proficiency Testing, by Gordon L. Love, MD, FCAP, and Julie A. Ribes, MD, FCAP, is an up-to-date resource that assists pathologists and medical technologists in the laboratory identification of fungi using the most recent taxonomic classifications. The text includes more than 15 years of proficiency testing data to highlight diagnostic clusters of incorrect identifications and address conceptual classification issues.

Hospital-based physicians urged quality improvement organizations to protect patients from high medical bills by setting oversight standards to ensure health plans maintain adequate numbers of in-network providers at hospitals.

CAP, ASCP and ASH open draft of interdisciplinary lymphoma diagnostic guideline for public comment

CAP portfolio of continuing medical education is now available through CME Finder, a resource of the Accreditation Council for Continuing Medical Education.

College of American Pathologists (CAP) President R. Bruce Williams, MD, FCAP issued the following statement after the U.S. District Court for the District of Columbia in American Clinical Laboratory Association (ACLA) v Azar

A CAP position statement creating solutions for combating the opioid crisis by performing the right laboratory tests and ensuring that patients have access to safer and more effective chronic pain treatment while reducing the risk of opioid use disorder, overdose and death.